Navigation Links
InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
Date:5/25/2011

r 2011 as follows:

  • R&D expense:  anticipated to be in a range of approximately $85 to $95 million.
  • SG&A expense:  anticipated to be in a range of approximately $65 to $75 million.  

Webcast Information – May 26, 8:30 a.m. EDT

To access the webcast of the Analyst Day presentations, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at www.intermune.com.  The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About Pirfenidone

Pirfenidone is an orally active, small molecule drug that inhibits the synthesis of TGF-beta, a chemical mediator that controls many cell functions including proliferation and differentiation, and plays a key role in fibrosis. It also inhibits the synthesis of TNF-alpha, a cytokine that is known to have an active role in inflammation.

On February 28, 2011, the European Commission (EC) granted marketing authorization for Esbriet® (pirfenidone) for the treatment of adults with mild to moderate IPF. The approval authorizes marketing of Esbriet in all 27 EU member states. Esbriet has since been approved for marketing in Norway and Iceland.

Since 2008, pirfenidone has been marketed in Japan as Pirespa® by Shionogi & Co. Ltd. Pirfenidone is still under investigation for the treatment of IPF in the United States and has not been approved by the U.S. Food and Drug Administration for this use. InterMune currently plans to conduct ASCEND, a new Phase 3 study, toward the goal of bringing pirfenidone to IPF patients in the United States, and currently expects to enroll the first patient in ASCEND in June 2011.

About IPF

Idiopathic pulmona
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
2. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
3. InterMune to Present at J.P. Morgan Healthcare Conference
4. InterMune Reports Third Quarter 2010 Financial Results
5. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
6. InterMune to Release Second Quarter Financial Results on July 27
7. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
8. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
9. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
10. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
11. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  Paper Pak ... has developed APLS ® Body Guard Bio, ... the spread of bacteria and virus while protecting ... Body Guard Bio features a rugged, external nylon ... that create a leak-proof inner chamber that contains ...
(Date:10/22/2014)... Oct. 22, 2014  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... Chief Executive Officer, has been elected to the Company,s ... Steven G. Anderson , Executive Chairman of CryoLife, stated, ... to be an excellent leader who is well positioned ...
(Date:10/22/2014)... 21, 2014   BioNano Genomics , the ... research centers to purchase an Irys™ System . ... Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) and ... obtaining a comprehensive view of a genome was ... does not deliver the scalability or reliability to ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
... Cancer treatment experts today reported their experiences with early ... Systems (NYSE: VAR ), aimed at increasing ... Clinicians from the first two European hospitals to start ... University Hospital in Switzerland and VU University Medical Center ...
... Waters Corporation (NYSE: WAT ) today introduced ... approach for the removal of phospholipids from biological samples. ... liquid-liquid extraction (LLE) methods, Ostro removes up to 30 ... as a major cause of matrix effects in the ...
Cached Medicine Technology:Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments 2Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments 3Waters Introduces Ostro Sample Preparation Products 2
(Date:10/25/2014)... safe and sound is one of the best Halloween treats ... and goody bags have reflective strips that improve visibility to ... Meadowlands Hospital Medical Center in Secaucus, N.J. Trick-or-treaters ... Davis said. He offers these others tips: ... small area of skin first to ensure it doesn,t cause ...
(Date:10/25/2014)... October 25, 2014 Market ... Diagnostics Industry, 2009-2019 is a professional and ... Molecular Diagnostics industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Molecular Diagnostics listing their product ...
(Date:10/25/2014)... October 25, 2014 Limbkeepers® announced today ... of Innovations with Ed Begley Jr, airing 1st QTR ... , In this episode, Innovations will focus on Limbkeepers® ... protect fragile, thinning skin on arms, hands, and legs ... about these versatile products, which help reduce injuries, allow ...
(Date:10/25/2014)... A large influx of international aid is needed, and ... thousands of deaths from the widening Ebola crisis, a ... a specially designed mathematical model, the researchers looked at ... densely populated county of hard-hit Liberia -- Montserrado County, ... researchers said that if international aid isn,t delivered to ...
(Date:10/22/2014)... 22, 2014 On Saturday, October 25, 2014, ... annual family health and fitness fair ¡Vive tu vida! Get ... and good nutrition for better health and wellness for people ... free and open to the public, will be held at ... 9:00 am to 1:00 pm. , “¡Vive tu Vida! ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... - Scientists from the Hebrew University have identified the molecular ... findings of this research have just been published in the ... the entire genetic information required for building the proteins of ... to changes in the cell function. These changes can lead ...
... of the brain,s master circadian clock known as the ... of rhythmic neural activity begins to decline by middle age. ... may have implications for the large number of older people ... "Aging has a profound effect on circadian timing," ...
... , TUESDAY, July 19 (HealthDay News) -- Following up ... for a long time have more gray matter in their ... shrink less as they age and they have stronger connections ... may better relay electrical signals, researchers said. "Our results ...
... triggering another, but explanations for that phenomenon have proved ... first neurobiological evidence that memories formed in the same ... episodic memory. The research was conducted by professor ... School of Arts and Sciences and graduate student Jeremy ...
... By Serena Gordon HealthDay Reporter , MONDAY, July 18 ... ride in a car driven by grandparents because they believe the ... But, new research suggests that children are actually safer in auto ... parent. As a matter of fact, the odds of ...
... , MONDAY, July 18 (HealthDay News) -- Melanoma, the ... by patients themselves, but new research reveals that self-detection ... In the study, conducted by researchers at Memorial ... found that in addition to higher rates of physician-detected ...
Cached Medicine News:Health News:Hebrew U. scientists identify molecular basis for DNA breakage 2Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 2Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 3Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 4Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 5Health News:Does Meditation Boost Brain Health? 2Health News:Penn researchers find neural signature of 'mental time travel' 2Health News:Kids Fare Better in Crashes When Grandparents Driving: Study 2Health News:Kids Fare Better in Crashes When Grandparents Driving: Study 3Health News:Specialists More Likely to Spot Deadly Skin Cancer 2
... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ...
... 2000 assays are designed ... IMMULITE 2000, a high-throughput, ... analyzer. IMMULITE 2000 offers ... and a rapidly expanding ...
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Inquire...
Medicine Products: